The use of clozapine in neurologic disorders.
The advent of clozapine has marked a major advance in the treatment of schizophrenia because of its low incidence of extrapyramidal side effects and superior efficacy. Because of a relatively high incidence of agranulocytosis, approved indications for use are limited to treatment-refractory or neuroleptic-intolerant patients with schizophrenia. However, an emerging body of literature suggests that clozapine may be preferable to typical neuroleptics for treating psychosis in certain neurologic disorders. In addition, clozapine may have a place in the treatment of movement disorders that are caused by or are a result of the pharmacologic treatment of some neurologic illnesses. In general, clozapine doses used in these settings are lower than that for treating psychosis in schizophrenia. This article reviews the experience with clozapine in selected neurologic disorders.
Safferman
A Z
AZ
Hillside Hospital-Psychiatry Research, Glen Oaks, N.Y.
Kane
J M
JM
Aronowitz
J S
JS
Gordon
M F
MF
Pollack
S
S
Lieberman
J A
JA
D002986:Clinical Trials as Topic; D003024:Clozapine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009422:Nervous System Diseases / Q000188:drug therapy*; D019965:Neurocognitive Disorders / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000188:drug therapy / Q000523:psychology; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy
D007980:Levodopa; D003024:Clozapine